|
|
Article: Palmetto GBA to Reimburse Full Medicare Amount for Zemplar.
- Article from:
- PR Newswire
- Article date:
- August 7, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
COLUMBIA, S.C., Aug. 7 /PRNewswire/ -- A new research study indicating a better survival rate for chronic kidney disease patients treated with a specific type of Vitamin D preparation has prompted Palmetto GBA to reimburse Medicare providers the full reimbursement amount available under the Medicare benefit.
Prior to this change, Palmetto GBA reimbursed equally for two Vitamin D preparations commonly used to treat chronic kidney disease. The policy change is effective immediately, according to Dr. Harry Feliciano, director of medical affairs for Medicare Part A at Palmetto GBA.
The study, published July 31, 2003 in The New England Journal of Medicine, ...